Men with ANCA-associated vasculitis (AAV) are three times more likely to develop cancer, most often that affecting the lungs…
Articles by Patricia Inacio, PhD
Undergoing plasma exchange or low-dose glucocorticoid therapy did not affect the risk of relapse in people with ANCA-associated vasculitis…
Two blood parameters — interleukin 8 (IL-8) and the neutrophil/lymphocyte ratio (NLR) — may help identify ANCA-associated vasculitis (AAV)…
Most people with ANCA-associated vasculitis (AAV) experience acute or chronic kidney injury, according to a five-year national study in the…
Long-term treatment with benralizumab — sold as Fasenra for a rare type of asthma — safely leads to clinical…
Treatment with Nucala (mepolizumab) for three or more years is safe, and was effective at easing symptoms and reducing…
In people with ANCA-associated vasculitis (AAV), evaluating kidney function by a test known as the estimated glomerular filtration rate…
ANCA-associated vasculitis (AAV) with kidney involvement is the most common cause of kidney disease among elderly people, but most…
Lower-than-normal counts of lymphocytes, a type of immune cell, are linked to a higher risk of severe infection in older…
The ANCA Renal Risk Score, known as the ARRS, was found to be better than standard methods at predicting the…